Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
1.500
-0.150 (-9.09%)
At close: Apr 1, 2025, 4:00 PM
1.530
+0.030 (2.00%)
After-hours: Apr 1, 2025, 5:30 PM EDT

Q32 Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-47.73-53.74-42.81-37.56
Depreciation & Amortization
0.490.50.370.05
Other Amortization
0.190.090.10.1
Loss (Gain) From Sale of Assets
--0.02-
Loss (Gain) From Sale of Investments
0.45---
Loss (Gain) on Equity Investments
1.63---
Stock-Based Compensation
4.391.431.240.75
Other Operating Activities
-17.496.743.18-
Change in Accounts Payable
-1.042.03-1.241.1
Change in Unearned Revenue
--25.8525.85-
Change in Other Net Operating Assets
-8.5950.132.342.58
Operating Cash Flow
-67.72-18.68-10.96-32.98
Capital Expenditures
-0.08-0.01-2.49-0.16
Sale of Property, Plant & Equipment
--0.02-
Investment in Securities
20---
Investing Cash Flow
19.93-0.01-2.47-0.16
Long-Term Debt Issued
75.530-
Long-Term Debt Repaid
--5.2--
Net Debt Issued (Repaid)
70.330-
Issuance of Common Stock
43.690.110.070.12
Other Financing Activities
44.44---
Financing Cash Flow
95.140.4130.0720.11
Net Cash Flow
47.35-18.2816.65-13.03
Free Cash Flow
-67.79-18.68-13.44-33.14
Free Cash Flow Margin
---202.10%-
Free Cash Flow Per Share
-7.02-53.52-1.91-5.12
Levered Free Cash Flow
-37.95-41.84-8.73-
Unlevered Free Cash Flow
-37.27-40.68-8.83-
Change in Net Working Capital
0.7512.44-16.57-
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q